14
Views
0
CrossRef citations to date
0
Altmetric
Review

Inhibition of post-ischaemic inflammation as a therapeutic approach to myocardial ischaemia reperfusion injury

, , &
Pages 1395-1404 | Published online: 25 Feb 2005

Bibliography

  • PATEL B, KLONER RA, PRZYKLENK K, BRAUNWALD E:Po stischemic myocardial 'stunning': a clinically relevant phenomenon. Ann. Int. Med. (1 98 8) 108:626–628.
  • MAES A, VAN DE WERF F, NUYTS J et al: Impairedmyocardial tissue perfusion early after successful thrombolysis. Circulation (1995) 92:2072–2078.
  • SILVERMAN HS, STERN MD: Ionic basis of ischaemic cardiac injury: insights from cellular studies. Cardio-vasc. Res. (1994) 28:581–597.
  • JEROME SN, AKIMITSU T, KORTHUIS RJ: leukocyte adhesion, edema and development of postischemic capillary no-reflow. Am. J Physiol (1994) 267:H1329–H1336.
  • FRANGOGIANNIS NG, YOUKER KA, ROSSEN RD et al: Cytokines and the microcirculation in ischemia and reperfusion. j Mol. Cell. Cardiol. (1998) 30:2567–2576.
  • LEFER AM, TSAO PS, LEFER DJ, MA XL: Role of endothe-lial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J. (1991) 5:2029–2034.
  • KUPATT C, ZAHLER S, SELIGMANN C et al.: Nitric oxidemitigates leukocyte adhesion and vascular leak after myocardial ischemia. J. Mol. Cell. Cardiol (1996) 28:643–654.
  • ENTMAN ML, YOUKER K, SHOJI T et al.: Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD1 8-ICAM-1 adherence. J Clin. Invest. (1992) 90:1335–1345.
  • POON BY, WARD CA, GILES WR, KUBES P: Emigrated neutrophils regulate ventricular contractility via alpha4 integrin. Cir. Res. (1999) 84:1245–1251.
  • KUPATT C, HABAZETTL H, HANUSCH P et al.: c7E3Fabreduces postischemic leukocyte-thrombocyte interac-tion mediated by fibrinogen: implications for myocar-dial reperfusion injury. Arterioscler. Thromb. Vasc. (2000): [In Press].
  • KUPATT C, HABAZETTL H, ZAHLER S et al.: ACE-inhibition prevents postischemic coronary leukocyte adhesion and leukocyte-dependent rep erfu-sion injury. Cardiovasc. Res. (1997) 3 6 :386–395.
  • LEFER DJ, SHANDELYA SM, SERRANO CVJ et al.: Cardio-protective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury. Circulation (1993) 88: 1779-1787.
  • SIMPSON PJ, TODD RF, FANTONE JC et al.: Reduction ofexperimental canine myocardial rep erfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J. Clin. Invest. (1988) 81:624–629.
  • SALA A, ROSSONI G, BERTI F et al.: Monoclonalan ti-CD18 antibody prevents transcellular biosyn-thesis of cysteinylleukotrienes in vitro and in vivo and protects against leukotriene-dependent increase in coronary vascular resistance and myocardial stiffness. (2000) 101:1436-1440.
  • TANAKA M, BROOKS SE, RICHARD VJ et al.: Effect ofanti-CD1 8 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs. Circulation (1993) 87:526–535.
  • FRANGOGIANNIS NG, LINDSEY ML, MICHAEL LH et al.:Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfu-sion. Circulation (1998) 98:699–710.
  • WADDELL TK, FIALKOW L, CHAN CK, KISHIMOTO TK,DOWNEY GP: Potentiation of the oxidative burst of human neutrophils. A signaling role for L-selectin.. Chem. (1994) 269:18485–18491.
  • ZAHLER S, MASSOUDY P, HARTL H et al.: Acute cardiacinflammatory responses to postischemic reperfusion during cardiopulmonary bypass. Cardiovasc. Res. (1999) 41:722–730.
  • MARX N, NEUMANN FJ, OTT I et al.: Induction ofcytokine expression in leukocytes in acute myocardial infarction. j Am. Coll Cardiol (1997) 30:165–170.
  • KUMAR AG, BALLANTYNE CM, MICHAEL LH et al.: Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation (1997) 95:693–700.
  • SERRANO CV, JR., MIKHAIL EA, WANG P et al.: Superoxide and hydrogen peroxide induce CD18-mediated adhesion in the postischemic heart. Biochim. Biophys. Acta (1996) 1316:191–202.
  • DUSTIN ML, SPRINGER TA: T cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. (1988) 341:619–624.
  • DIAMOND MS, SPRINGER TA: A subpopulation of Mac-1(CD11b/CD1 8) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol. (1993) 1 2 0:545–556.
  • HENTZEN ER, NEELAMEGHAM S, KANSAS GS et al.: Sequential binding of CD11a/CD18 and CD11b/CD18 defines neutrophil capture and stable adhesion to intercellular adhesion molecule-1. Blood (2000) 95:911–920.
  • LUB M, VANKOOYK Y, FIGDOR CG: Competition between lymphocyte function-associated antigen 1 (CD11a/CD18) and Mac-1 (CD11b/CD18) for binding to intercellular adhesion molecule-1 (CD54). j Leukoc. Biol. (1996) 59:648–655.
  • LU H, SMITH CW, PERRARD J et al.: LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J. Clin. Invest. (1997) 99:1340–1350.
  • KELLY KJ, WILLIAMS WWJ, COLVIN RB etal.: Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin. Invest. (1996) 97:1056–1063.
  • CONNOLLY ESJ, WINFREE CJ, SPRINGER TA et al.: Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutro-phil adhesion in the pathogenesis of stroke. J Clin. Invest. (1996) 97:209–216.
  • PALAZZO AJ, JONES SP, GIROD WG et al: Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice. Am. J Physiol. (1998) 275:H2300–H2307.
  • MA XL, TSAO PS, LEFER AM: Antibody to CD-18 exerts endothelial and cardiac protective effects in myocar-dial ischemia and reperfusion. j Clin. Invest. (1991) 88:1237–1243.
  • WEYRICH AS, ELSTAD MR, MCEVER RP et al: Activated platelets signal chemokine synthesis by human monocytes.j an. Invest. (1996) 97:1525–1534.
  • MILHOAN KA, LANE TA, BLOOR CM: Hypoxia induces endothelial cells to increase their adherence for neutrophils: role of PAF. Am. J. Physiol. (1992) 263:H956–H962.
  • NEUMANN FJ, MARX N, GAWAZ M et al: Induction ofcytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation (1997) 95:2387–2394.
  • GAWAZ M, BRAND K, DICKFELD T et al.: Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for athero-genesis. Atherosclerosis (2000) 148:75–85.
  • WEBER C, SPRINGER TA: Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of Mac-1 with fibrinogen bound to alpha 2 beta 3 and stimulated by platelet-activating factor. J an. Invest. (1997) 100:2085–2093.
  • EVANGELISTA V, MANARINI S, SIDERI R et al.: Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood (1999) 93 :876–885.
  • NEUMANN FJ, ZOHLNHOFER D, FAKHOURY L et al.: Effect of glycoprotein IIb/Illa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. j Am. Coll. Cardiol. (1999) 34:1420–1426.
  • KUIJPER PH, GALLARDO TORRES HI, VAN DER LINDEN JA et al.: Platelet-dependent primary hemostasis promotes selectin- and integrin- mediated neutrophil adhesion to damaged endothelium under flow conditions. Blood (1996) 87:3271–3281.
  • KUPATT C, HABAZETTL H, WOLF DA et al.: TNF alpha contributes to ischemia/reperfusion induced activation in isolated hearts. Circ. Res. (1999) 84:392–400.
  • LIOU H-C, BALTIMORE D: Regulation of the NF-kappaB/rel transcription factor and I Kappa B inhibitor system. Curr. Opin. Cell Biol. (1993) 5:477–487.
  • KARIN M: The beginning of the end: I kappa B kinase HI(K) and NF kappa B activation. J Biol. Chem. (1999) 274:27339–27342.
  • HEYMANS S, LUTTUN A, NUYENS D et al.: Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nature Med. (1999) 5:1135–1142.
  • KUBES P, JUTILA M, PAYNE D: Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. Clin. Invest. (1995) 95:2510–2519.
  • MASSBERG S, ENDERS G, LEIDERER R et al.: Platelet-endothelial cell interactions during ischemia/reperfu-sion: the role of P-selectin. Blood (1998) 92:507–515.
  • LEFER AM, CAMPBELL B, SCALIA R, LEFER DJ: Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. Circulation (1998) 98:1322–1328.
  • GENG JG, BEVILACQUA MP, MOORE KL et al.: Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature (1990) 343:757–760.
  • ZAHLER S, KUPATT C, BECKER BF: Endothelial precon-ditioning by transient oxidative stress reduces inflam-matory responses of cultured endothelial cells to TNF-alpha. FASEB J (2000) 14:555–564.
  • VON ANDRIAN UH, HASSIEN SR, NELSON RD, ERLANDSEN SL, BUTCHER EC: A central role for microvillous receptor presentation in leukocyte adhesion under flow. Cell (1995) 82:989–999.
  • WALCHECK B, KAHN J, FISHER JM et al.: Neutrophilrolling altered by inhibition of L-selectin shedding in vitro. Nature (1996) 380:720–723.
  • NORGARD KE, MOORE KL, DIAZ S et al.: Characteriza-tion of a specific ligand for P-selection on myeloid cells. A minor glycoprotein with sialylated 0-linked oligosaccharides [published erratum appears in J.Biol Chem. 1993 268(30):22953]. J. Biol. Chem. (1993) 268:12764–12774.
  • LEFER DJ, FLYNN DM, PHILLIPS ML, RATCLIFFE M, BUDAAJ: A novel sialyl IzwisX analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and rep erfusion. Circulation (1994) 90:2390–2401.
  • MISUGI E, KAWAMURA N, IMANISHI N, TOJO SJ, MOROOKA S: Sialylizwis X moiety on rat polymorpho-nuclear leukocytes responsible for binding to rat E-selectin. Biochem. Biophys. Res. Comm. (1995) 215:547–554.
  • FLYNN DM, BUDA AJ, JEFFORDS PR, LEFER DJ: A sialylLewis(x)-containing carbohydrate reduces infarct size: role of selectins in myocardial reperfusion injury. Am. J Physiol. (1996) 271:H2086–H2096.
  • GO LO, MURRY CE, RICHARD VJ et al: Myocardial neutrophil accumulation during rep erfusion after reversible or irreversible ischemic injury. Am. J. Physic)]. (1988) 255:H1188–H1198.
  • LUCCHESI BR, WERNS SW, FANTONE JC: The role of the neutrophil and free radicals in ischemic myocardial injury. J. Mol. Cell. Cardiol. (1989) 21:1241–1251.
  • SAWA Y, TANIGUCHI K, KADOBA K et al.: leukocyte depletion attenuates reperfusion injury in patients with left ventricular hypertrophy. Circulation (1996) 93:1640–1646.
  • HAMMERMAN H, KLONER RA, HALE S, SCHOEN S, BRAUNWALD E: Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation and ventricular function. Circulation (1983) 68:446.
  • NEUMANN FJ, BLASINI R, SCHMITT C et al.: Effect of glycoprotein I1b/Illa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocar-dial infarction. Circulation (1998) 98:2695–2701.
  • TRAENCKNER EB-M, WILK S, BAEUERLE PA: A protea-some inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of IkB-alpha that is still bound to NF-kappa B. EMBO J. (1994) 13:5433–5441.
  • PALOMBELLA VJ, RANDO 0J, GOLDBERG AL, MANIATIS T: The ubiquitin-proteasome pathway is required for processing the NF-KB1 precursor protein and the activation of NF-KB. Cell (1994) 78:773–785.
  • ROCK KL, GRAMM C, ROTHSTEIN L et al.: Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell (1994) 78:761–771.
  • DREXLER HC, RISAU W, KONERDING MA: Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells. FASEB j (2000) 14:65–77.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.